Nothing Special   »   [go: up one dir, main page]

MA49379A - Synthèse de phosphate protides diastéréoisomériquement substantiellement purs - Google Patents

Synthèse de phosphate protides diastéréoisomériquement substantiellement purs

Info

Publication number
MA49379A
MA49379A MA049379A MA49379A MA49379A MA 49379 A MA49379 A MA 49379A MA 049379 A MA049379 A MA 049379A MA 49379 A MA49379 A MA 49379A MA 49379 A MA49379 A MA 49379A
Authority
MA
Morocco
Prior art keywords
pure
diasterereoisomerically
protides
synthesis
phosphate
Prior art date
Application number
MA049379A
Other languages
English (en)
French (fr)
Inventor
Venkata Lakshmi Narasimha Rao Dammalapati
Hugh Griffith
Gordon Kennovin
Mani Bushan Kotala
Original Assignee
NuCana plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NuCana plc filed Critical NuCana plc
Publication of MA49379A publication Critical patent/MA49379A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA049379A 2017-06-14 2018-06-14 Synthèse de phosphate protides diastéréoisomériquement substantiellement purs MA49379A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1709471.5A GB201709471D0 (en) 2017-06-14 2017-06-14 Diastereoselective synthesis of hosphate derivatives

Publications (1)

Publication Number Publication Date
MA49379A true MA49379A (fr) 2020-04-22

Family

ID=59358400

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049379A MA49379A (fr) 2017-06-14 2018-06-14 Synthèse de phosphate protides diastéréoisomériquement substantiellement purs

Country Status (18)

Country Link
US (3) US11897913B2 (es)
EP (2) EP3638685A1 (es)
JP (4) JP7248209B2 (es)
KR (2) KR20240127483A (es)
CN (3) CN110785425B (es)
AU (3) AU2018284131B2 (es)
BR (1) BR112019026747A2 (es)
CA (2) CA3064177A1 (es)
CL (1) CL2019003632A1 (es)
EA (1) EA201992873A1 (es)
GB (1) GB201709471D0 (es)
IL (3) IL271159B2 (es)
MA (1) MA49379A (es)
MX (3) MX2019014914A (es)
PH (1) PH12019502825A1 (es)
SA (1) SA519410795B1 (es)
SG (1) SG11201911543UA (es)
WO (2) WO2018229495A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933053B2 (en) 2011-03-01 2015-01-13 Nucana Biomed Limited Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
MX2020004054A (es) 2014-06-25 2021-11-30 NuCana plc Formulacion que comprende un profarmaco de gemcitabina.
SG11201702369UA (en) * 2014-11-28 2017-04-27 Nucana Biomed Ltd New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds
LT3386998T (lt) 2015-12-11 2022-01-25 NuCana plc Fosfato darinių ir gemcitabino provaisto nuc-1031 diastereoselektyvi sintezė
GB201522764D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Formulations of phosphate derivatives
GB201609600D0 (en) 2016-06-01 2016-07-13 Nucuna Biomed Ltd Cancer treatments
GB201709471D0 (en) 2017-06-14 2017-07-26 Nucana Biomed Ltd Diastereoselective synthesis of hosphate derivatives
GB201715011D0 (en) 2017-09-18 2017-11-01 Nucana Biomed Ltd Floxuridine synthesis
CN112409421A (zh) * 2020-12-01 2021-02-26 上海兆维科技发展有限公司 一种3’-磷酸酯核苷的制备方法
IL316821A (en) 2022-05-12 2025-01-01 NuCana plc Cancer treatment with NUC-7738
WO2024121527A1 (en) 2022-12-07 2024-06-13 NuCana plc Synthesis of nucleoside derivative nuc-3373

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE279248C (es)
US3792039A (en) 1971-12-27 1974-02-12 Miles Lab Poly 2'-fluoro-2'-deoxyuridylic acid
US4500707A (en) * 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4357324A (en) 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
US4668777A (en) * 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
JP2002500880A (ja) 1998-01-23 2002-01-15 ニューバイオティックス インコーポレイテッド 酵素に触媒される治療剤
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
GB0317009D0 (en) 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds
JP2008523082A (ja) 2004-12-09 2008-07-03 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 抗菌活性および抗癌活性を有するヌクレオチド
GB0505781D0 (en) 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
EP1928475B1 (en) 2005-08-15 2018-05-23 Riboscience LLC Antiviral phosphoramidates of 4'-c-azido-substituted pronucleotides
GB0623493D0 (en) 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
US20080261913A1 (en) * 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US20090206007A1 (en) 2008-02-20 2009-08-20 Air Products And Chemicals, Inc. Process and apparatus for upgrading coal using supercritical water
CA2749394A1 (en) 2009-01-09 2010-07-15 University College Of Cardiff Consultants Limited Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
US20100249068A1 (en) 2009-03-20 2010-09-30 Alios Biopharma, Inc. Substituted nucleoside and nucleotide analogs
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
PT2609923T (pt) 2010-03-31 2017-08-30 Gilead Pharmasset Llc Processo para a cristalização de 2-(((s)- (perfluorofenoxi)(fenoxi)fosforil)amino)propanoato de (s)-isopropilo
UY33312A (es) 2010-03-31 2011-10-31 Pharmasset Inc Fosforamidato de nucleosido de purina
EP2805960A1 (en) 2010-07-19 2014-11-26 Gilead Sciences, Inc. Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
WO2012040126A1 (en) 2010-09-22 2012-03-29 Alios Biopharma, Inc. Substituted nucleotide analogs
CN105061534A (zh) 2010-09-22 2015-11-18 艾丽奥斯生物制药有限公司 取代的核苷酸类似物
EP2646453A1 (en) 2010-11-30 2013-10-09 Gilead Pharmasset LLC Compounds
EP2655392B1 (en) 2010-12-22 2018-04-18 Alios Biopharma, Inc. Cyclic nucleotide analogs
US8933053B2 (en) 2011-03-01 2015-01-13 Nucana Biomed Limited Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
WO2014033617A1 (en) 2012-08-31 2014-03-06 Novartis Ag 2'-ethynyl nucleoside derivatives for treatment of viral infections
PT3150616T (pt) 2012-11-16 2017-06-09 Univ College Cardiff Consultants Ltd Mistura de rp/sp gencitabina-[fenil-(benziloxi-l-alaninil)]-fosfato
AU2014302711A1 (en) 2013-06-26 2015-12-10 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
ES2927955T3 (es) 2013-09-11 2022-11-14 Univ Emory Composiciones de nucleótidos y nucleósidos y sus usos
MX2016004558A (es) 2013-10-11 2016-07-06 Alios Biopharma Inc Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
US10030044B2 (en) 2013-11-27 2018-07-24 Idenix Pharmaceuticals Llc Nucleotides for the treatment of liver cancer
CZ307789B6 (cs) 2014-04-15 2019-05-09 Zentiva, K.S. Způsob výroby biologicky účinných fosforamidátových léčiv
US10202411B2 (en) 2014-04-16 2019-02-12 Idenix Pharmaceuticals Llc 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV
HUE053240T2 (hu) 2014-06-25 2021-06-28 NuCana plc Gemcitabin prodrugok
MX2020004054A (es) 2014-06-25 2021-11-30 NuCana plc Formulacion que comprende un profarmaco de gemcitabina.
EP3172218B1 (en) 2014-07-22 2020-10-21 NuCana plc Process for the preparation of gemcitabine-[phenyl(benzoxy-l-alaninyl)] phosphate
EP3186244B1 (en) * 2014-08-25 2020-04-22 Medivir Aktiebolag Dioxolane analogues of uridine for the treatment of cancer
GB201417644D0 (en) 2014-10-06 2014-11-19 Nucana Biomed Ltd Method of separating phosphate diastereoisomers
CN105646629A (zh) 2014-11-25 2016-06-08 广州市恒诺康医药科技有限公司 L-核苷类化合物及其应用
SG11201702369UA (en) 2014-11-28 2017-04-27 Nucana Biomed Ltd New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds
WO2016098123A2 (en) * 2014-12-16 2016-06-23 Laurus Labs Private Ltd A recycling process for preparing (s)-2-[(substituted-phenoxy)-phenoxy- phosphorylamino] propionic acid isopropyl ester diastereomers
WO2016145142A1 (en) 2015-03-10 2016-09-15 Emory University Nucleotide and nucleoside therapeutics compositions and uses related thereto
ES2668377T3 (es) 2015-05-14 2018-05-17 NuCana plc Tratamientos contra el cáncer
CN106539810B (zh) 2015-09-16 2021-03-09 济南高合医疗科技有限公司 一种富集了nuc-1031单一异构体的组合物及其制备方法和用途
CN106543252A (zh) 2015-09-16 2017-03-29 博瑞生物医药（苏州）股份有限公司 核苷氨基磷酸酯类前药的制备方法及其中间体
CN106543220A (zh) 2015-09-16 2017-03-29 博瑞生物医药（苏州）股份有限公司 氨基磷酸酯化合物及其制备方法和晶体
CN108135920A (zh) 2015-10-05 2018-06-08 努卡那有限公司 组合疗法
WO2017087517A1 (en) * 2015-11-16 2017-05-26 Demeter Therapeutics, Llc Nucleic acid prodrugs
LT3386998T (lt) 2015-12-11 2022-01-25 NuCana plc Fosfato darinių ir gemcitabino provaisto nuc-1031 diastereoselektyvi sintezė
GB201522764D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Formulations of phosphate derivatives
MX2018007772A (es) 2015-12-23 2019-07-04 NuCana plc Terapia de combinacion.
GB201609601D0 (en) 2016-06-01 2016-07-13 Nucana Biomed Ltd Phosphoramidate compounds
GB201609602D0 (en) * 2016-06-01 2016-07-13 Nucuna Biomed Ltd Chemical compounds
GB201609600D0 (en) 2016-06-01 2016-07-13 Nucuna Biomed Ltd Cancer treatments
GB201709471D0 (en) * 2017-06-14 2017-07-26 Nucana Biomed Ltd Diastereoselective synthesis of hosphate derivatives
GB201713916D0 (en) 2017-08-30 2017-10-11 Nucana Biomed Ltd Treatment regimens

Also Published As

Publication number Publication date
JP2020523381A (ja) 2020-08-06
US12054511B2 (en) 2024-08-06
AU2024200428A1 (en) 2024-02-08
CA3064177A1 (en) 2018-12-20
WO2018229493A3 (en) 2019-02-07
GB201709471D0 (en) 2017-07-26
SA519410795B1 (ar) 2023-11-19
US11414452B2 (en) 2022-08-16
JP2024138523A (ja) 2024-10-08
WO2018229493A2 (en) 2018-12-20
EA201992873A1 (ru) 2020-05-19
US20220402962A1 (en) 2022-12-22
JP7279991B2 (ja) 2023-05-23
CN110785425B (zh) 2023-11-21
CN110753697A (zh) 2020-02-04
AU2018284131A1 (en) 2020-01-16
CN117486959A (zh) 2024-02-02
KR102695300B1 (ko) 2024-08-16
IL271159A (en) 2020-01-30
IL312228B1 (en) 2025-02-01
SG11201911543UA (en) 2020-01-30
KR20200016864A (ko) 2020-02-17
JP2020523378A (ja) 2020-08-06
IL302559A (en) 2023-07-01
CL2019003632A1 (es) 2020-08-14
JP2023095954A (ja) 2023-07-06
JP7248209B2 (ja) 2023-03-29
CN110785425A (zh) 2020-02-11
US11897913B2 (en) 2024-02-13
PH12019502825A1 (en) 2020-10-26
MX2019014914A (es) 2020-02-13
IL312228A (en) 2024-06-01
IL302559B1 (en) 2024-05-01
MX2022003822A (es) 2022-05-25
US20200181190A1 (en) 2020-06-11
EP3638684A2 (en) 2020-04-22
WO2018229495A1 (en) 2018-12-20
AU2018284131B2 (en) 2022-04-07
EP3638685A1 (en) 2020-04-22
AU2022204691B2 (en) 2023-11-23
BR112019026747A2 (pt) 2020-06-30
US20200181186A1 (en) 2020-06-11
JP7525687B2 (ja) 2024-07-30
AU2022204691A1 (en) 2022-08-04
KR20240127483A (ko) 2024-08-22
IL302559B2 (en) 2024-09-01
CN110753697B (zh) 2023-10-13
CA3065682A1 (en) 2018-12-20
IL271159B2 (en) 2023-10-01
IL271159B1 (en) 2023-06-01
MX2019014907A (es) 2020-02-13

Similar Documents

Publication Publication Date Title
MA49379A (fr) Synthèse de phosphate protides diastéréoisomériquement substantiellement purs
EP3711813C0 (en) BEAUTY MASK
UA37664S (uk) Елемент взуття
EP3381179C0 (en) HANDLING MULTIPLE HDR IMAGE SOURCES
MA46180A (fr) Analogues de l'amyline
LT3645518T (lt) Omekamitivo mekarbilo sintezė
EP3479817A4 (en) COSMETIC PRODUCT.
EP3360010A4 (en) BI PHOTONS WITH VOTABLE SOURCE
EP3406336A4 (en) NANO FOIL OF CORE CASE STRUCTURE TYPE
EP3347334A4 (en) DEHYDROHALOGENICATION OF FLUOROCHOLE HYDROGEN
EP3430929A4 (en) TYPE VARIABLE HELMET
EP3291722A4 (en) IMPROVED LENS OPPORTER
EP3468484A4 (en) COAST SURGICAL RETRACTOR
EP3277701A4 (en) SYNTHESIS OF DESOSAMINES
EP3602613A4 (en) THREE-DIMENSIONAL SEMICONDUCTOR MANUFACTURING
EP3394130A4 (en) Terephthalate CO BIBENZOATPOLYESTER
EP3387469A4 (en) ELEKTROFAZIENBESTIMMUNG
KR20180084983A (ko) 암의 치료를 위한 피리미도-피리미다지논의 용도
EP3297783A4 (en) PROJECTOR SUN GUARD
UY36306A (es) Sintesis de ent-progesterona e intermediarios de la misma
EP3714863C0 (en) COSMETIC PRODUCT
LT3652187T (lt) Patobulintas imetelstato gamybos būdas
FR3025098B1 (fr) Composition cosmetique de type gel facilement demaquillable
EP3656276A4 (en) ENDOSCOPE
FR3038213B1 (fr) Boitier cosmetique de type poudrier